Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.68
Delayed Data
As of Jul 26
 +0.04 / +2.44%
Today’s Change
1.19
Today|||52-Week Range
4.42
-45.63%
Year-to-Date
No recent news for Idera Pharmaceuticals Inc.

Today’s Trading

Previous close1.64
Today’s open1.64
Day’s range1.63 - 1.68
Volume150,845
Average volume (3 months)774,602
Market cap$198.9M
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)+10.64%
Earnings growth (this year)-5.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+241.10%
P/E ratioNM
Price/Sales1,428.25
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
CCXIChemoCentryx Inc+0.10+2.25%
VTLVital Therapies Inc+0.06+0.94%
GLYCGlycoMimetics Inc-0.04-0.47%
AGRXAgile Therapeutics I...-0.06-0.89%
Data as of 07/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$249.0K
Annual profit (last year)-$48.6M
Net profit margin-19,500.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vin Milano
CFO, Treasurer &
Senior Vice President-Operations
Louis J. Arcudi
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs